Mediwound Ltd MDWD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
18.65UNCH (UNCH)
Volume
296
Close
18.65quote price arrow down-0.19 (-1.01%)
Volume
40,121
52 week range
7.10 - 19.86
Loading...
  • Open18.84
  • Day High19.29
  • Day Low18.37
  • Prev Close18.84
  • 52 Week High19.86
  • 52 Week High Date05/01/24
  • 52 Week Low7.10
  • 52 Week Low Date09/08/23

Key Stats

  • Market Cap134.869M
  • Shares Out7.23M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change83.38

KEY STATS

  • Open18.84
  • Day High19.29
  • Day Low18.37
  • Prev Close18.84
  • 52 Week High19.86
  • 52 Week High Date05/01/24
  • 52 Week Low7.10
  • 52 Week Low Date09/08/23
  • Market Cap134.869M
  • Shares Out7.23M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change83.38

RATIOS/PROFITABILITY

  • EPS (TTM)-0.77
  • P/E (TTM)-24.28
  • Fwd P/E (NTM)-9.73
  • EBITDA (TTM)-13.987M
  • ROE (TTM)-31.60%
  • Revenue (TTM)18.686M
  • Gross Margin (TTM)19.15%
  • Net Margin (TTM)-35.94%
  • Debt To Equity (MRQ)20.10%

EVENTS

  • Earnings Date05/28/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Mediwound Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar...
Stephen Wills CPA
Independent executive Chairman of the board
Sharon Malka
Chief Executive Officer
Shmulik Hess
Chief Operating Officer, Chief Compliance Officer
Boaz Gur-Lavie
Chief Financial Officer
Lior Rosenberg M.D.
Chief Medical Technology Officer
Yaron Meyer
Executive Vice President, General Counsel, Corporate Secretary
Address
42 Hayarkon Street
Yavne
8122745
Israel